Search Results - "Garnett, C E"

Refine Results
  1. 1

    Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science by Johannesen, L, Vicente, J, Gray, R A, Galeotti, L, Loring, Z, Garnett, C E, Florian, J, Ugander, M, Stockbridge, N, Strauss, D G

    Published in Clinical pharmacology and therapeutics (01-05-2014)
    “…Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes. Most drugs that cause torsade can be identified by assessing…”
    Get full text
    Journal Article
  2. 2

    Boosting Solar Cell Photovoltage via Nanophotonic Engineering by Cui, Y, van Dam, D, Mann, S. A, van Hoof, N. J. J, van Veldhoven, P. J, Garnett, E. C, Bakkers, E. P. A. M, Haverkort, J. E. M

    Published in Nano letters (12-10-2016)
    “…Approaching the theoretically limiting open circuit voltage (V oc) of solar cells is crucial to optimize their photovoltaic performance. Here, we demonstrate…”
    Get full text
    Journal Article
  3. 3

    Growth and Electrical Characteristics of Platinum-Nanoparticle-Catalyzed Silicon Nanowires by Garnett, E. C., Liang, W., Yang, P.

    Published in Advanced materials (Weinheim) (05-10-2007)
    “…Pt nanoparticle catalysts are used to synthesize Si nanowires. The standard deviations of the starting colloid and the resulting wire diameters are essentially…”
    Get full text
    Journal Article
  4. 4

    A Modeling and Simulation Approach to Characterize Methadone QT Prolongation Using Pooled Data From Five Clinical Trials in MMT Patients by Florian, J, Garnett, C E, Nallani, S C, Rappaport, B A, Throckmorton, D C

    Published in Clinical pharmacology and therapeutics (01-04-2012)
    “…Pharmacokinetic (PK)‐pharmacodynamic modeling and simulation were used to establish a link between methadone dose, concentrations, and Fridericia…”
    Get full text
    Journal Article
  5. 5

    Effects of Nafion as a binding agent for unsupported nanoparticle catalysts by McGovern, M.S., Garnett, E.C., Rice, C., Masel, R.I., Wieckowski, A.

    Published in Journal of power sources (27-03-2003)
    “…We studied the effect of Nafion on the formic acid oxidation reactivity of three unsupported nanoparticle catalysts: Pt black, Pt/Ru black, and Pt/Pd. The…”
    Get full text
    Journal Article
  6. 6

    Au-Cu2O core-shell nanowire photovoltaics by Oener, S. Z., Mann, S. A., Sciacca, B., Sfiligoj, C., Hoang, J., Garnett, E. C.

    Published in Applied physics letters (12-01-2015)
    “…Semiconductor nanowires are among the most promising candidates for next generation photovoltaics. This is due to their outstanding optical and electrical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Hybrid Silicon Nanocone–Polymer Solar Cells by Jeong, Sangmoo, Garnett, Erik C, Wang, Shuang, Yu, Zongfu, Fan, Shanhui, Brongersma, Mark L, McGehee, Michael D, Cui, Yi

    Published in Nano letters (13-06-2012)
    “…Recently, hybrid Si/organic solar cells have been studied for low-cost Si photovoltaic devices because the Schottky junction between the Si and organic…”
    Get full text
    Journal Article
  9. 9

    Au-Cu{sub 2}O core-shell nanowire photovoltaics by Oener, S. Z., Mann, S. A., Sciacca, B., Sfiligoj, C., Hoang, J., Garnett, E. C.

    Published in Applied physics letters (12-01-2015)
    “…Semiconductor nanowires are among the most promising candidates for next generation photovoltaics. This is due to their outstanding optical and electrical…”
    Get full text
    Journal Article
  10. 10

    Different Anesthetic Sensitivities of Skeletal and Cardiac Isoforms of the Ca-ATPase by Karon, Brad S, Autry, Joseph M, Shi, Yongli, Garnett, Christine E, Inesi, Giuseppe, Jones, Larry R, Kutchai, Howard, Thomas, David D

    Published in Biochemistry (Easton) (20-07-1999)
    “…We have previously shown that low levels of the volatile anesthetic halothane activate the Ca-ATPase in skeletal sarcoplasmic reticulum (SR), but inhibit the…”
    Get full text
    Journal Article
  11. 11

    Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies by Florian, Jeffry A., Tornøe, Christoffer W., Brundage, Richard, Parekh, Ameeta, Garnett, Christine E.

    Published in Journal of clinical pharmacology (01-08-2011)
    “…To increase our understanding of important subject characteristics and design variables affecting the performance of oral moxifloxacin in thorough QT studies,…”
    Get full text
    Journal Article
  12. 12

    Are women more susceptible than men to drug‐induced QT prolongation? Concentration–QTc modelling in a phase 1 study with oral rac‐sotalol by Darpo, Borje, Karnad, Dilip R., Badilini, Fabio, Florian, Jeff, Garnett, Christine E, Kothari, Snehal, Panicker, Gopi Krishna, Sarapa, Nenad

    Published in British journal of clinical pharmacology (01-03-2014)
    “…Aim To study the differences in QTc interval on ECG in response to a single oral dose of rac‐sotalol in men and women. Methods Continuous 12‐lead ECGs were…”
    Get full text
    Journal Article
  13. 13

    Concentration-QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review by Garnett, Christin E., Beasley, Nhi, Bhattaram, V. Atul, Jadhav, Pravi R., Madabushi, Rajanikanth, Stockbridge, Norman, Tornøe, Christoffe W., Wang, Yaning, Zhu, Hao, Gobburu, Jogara V.

    Published in Journal of clinical pharmacology (01-01-2008)
    “…The criterion for assessing whether a drug prolongs QT as described in the International Conference on Harmonization topic E14 guideline does not explicitly…”
    Get full text
    Journal Article
  14. 14

    Creation of a Knowledge Management System for QT Analyses by Tornøe, Christoffer W., Garnett, Christine E., Wang, Yaning, Florian, Jeffry, Li, Michael, Gobburu, Jogarao V.

    Published in Journal of clinical pharmacology (01-07-2011)
    “…An increasing number of thorough QT (TQT) reports are being submitted to the US Food and Drug Administration's interdisciplinary review team for QT (IRT‐QT),…”
    Get full text
    Journal Article
  15. 15

    Silicon nanowire hybrid photovoltaics by Garnett, E C, Peters, C, Brongersma, M, Yi Cui, McGehee, M

    “…Silicon nanowire Schottky junction solar cells have been fabricated using n-type silicon nanowire arrays and a spin-coated conductive polymer (PEDOT). The…”
    Get full text
    Conference Proceeding
  16. 16

    A novel method to assess test-quality of phase-3 trials by Garnett, C. E., Nelson, J., Peck, C.

    Published in Clinical pharmacology and therapeutics (01-02-2004)
    “…Objectives To investigate new drug development programs, we piloted a method to assess “test‐quality” of phase‐3 trials. Methods. 40 phase‐3 trial results,…”
    Get full text
    Journal Article
  17. 17

    The relative importance of between subject correlation of clearance (CL) and volume of distribution (V) compared with correlation of estimation error when applied to pharmacokinetic (PK) simulation by Garnett, C. E., Holford, N. H.

    Published in Clinical pharmacology and therapeutics (01-02-2004)
    “…Purpose To describe the bias and imprecision of t1/2 when CL and V are simulated with and without correlations in the random effects (PPV) and standard errors…”
    Get full text
    Journal Article
  18. 18

    Phase-resolved surface plasmon scattering probed by cathodoluminescence holography by Schilder, N. J, Agrawal, H, Garnett, E. C, Polman, A

    Published 09-12-2019
    “…High-energy (1-100 keV) electrons can coherently couple to plasmonic and dielectric nanostructures creating cathodoluminescence (CL) of which the spectral…”
    Get full text
    Journal Article
  19. 19
  20. 20